Table 2.
Risk factor | Subgroup | Method | Sensitivity | Specificity | P-value | ||||
---|---|---|---|---|---|---|---|---|---|
Estimate (%) | LCI | UCI | Estimate (%) | LCI | UCI | ||||
Overall | None | GLMM | 62 | 58 | 66 | 41 | 38 | 44 | 0.13 |
GEE | 59 | 56 | 63 | 43 | 40 | 45 | 0.23 | ||
Age | 40 | GLMM | 50 | 42 | 58 | 53 | 46 | 60 | <0.001 |
50 | 55 | 49 | 60 | 48 | 44 | 53 | |||
60 | 59 | 54 | 63 | 44 | 41 | 47 | |||
70 | 63 | 59 | 67 | 40 | 37 | 43 | |||
80 | 67 | 62 | 71 | 36 | 32 | 40 | |||
40 | GEE | 50 | 43 | 57 | 52 | 46 | 58 | 0.006 | |
50 | 53 | 48 | 59 | 49 | 45 | 53 | |||
60 | 57 | 53 | 61 | 45 | 42 | 48 | |||
70 | 60 | 57 | 64 | 42 | 39 | 44 | |||
80 | 64 | 60 | 68 | 38 | 35 | 42 | |||
Smoking | Never | GLMM | 56 | 51 | 62 | 47 | 42 | 52 | 0.003 |
Former | 66 | 62 | 71 | 37 | 33 | 41 | |||
Current | 59 | 50 | 68 | 44 | 35 | 53 | |||
Never | GEE | 55 | 50 | 60 | 47 | 43 | 51 | 0.005 | |
Former | 63 | 59 | 67 | 39 | 36 | 43 | |||
Current | 57 | 49 | 65 | 45 | 38 | 52 | |||
Gender | Female | GLMM | 51 | 45 | 57 | 53 | 48 | 58 | <0.001 |
Male | 67 | 63 | 71 | 36 | 32 | 39 | |||
Female | GEE | 50 | 45 | 55 | 52 | 48 | 56 | <0.001 | |
Male | 64 | 60 | 67 | 38 | 35 | 41 | |||
Race | White | GLMM | 63 | 59 | 67 | 40 | 37 | 44 | 0.34 |
Black | 61 | 53 | 68 | 43 | 36 | 50 | |||
Other | 51 | 34 | 68 | 52 | 36 | 68 | |||
White | GEE | 60 | 56 | 64 | 42 | 39 | 45 | 0.25 | |
Black | 58 | 51 | 65 | 44 | 38 | 50 | |||
Other | 49 | 35 | 63 | 53 | 39 | 67 | |||
Indication | Hematuria | GLMM | 63 | 58 | 69 | 40 | 35 | 45 | 0.047 |
Cancer | 63 | 59 | 68 | 40 | 36 | 44 | |||
Other | 53 | 44 | 62 | 51 | 43 | 59 | |||
Hematuria | GEE | 61 | 56 | 65 | 42 | 38 | 46 | 0.059 | |
Cancer | 60 | 56 | 64 | 42 | 39 | 45 | |||
Other | 52 | 45 | 59 | 51 | 44 | 57 |